| Dr Mark Edmund Johnston, MD FRCSC | |
|
13330 N 74th St, Omaha, NE 68122-1919 | |
| (402) 639-3250 | |
| (402) 387-7967 |
| Full Name | Dr Mark Edmund Johnston |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 13330 N 74th St, Omaha, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851398168 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 31743 (Iowa) | Secondary |
| 207W00000X | Ophthalmology | 20412 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Edmund Johnston, MD FRCSC 13330 N 74th St, Omaha, NE 68122-1919 Ph: (026) 393-2504 | Dr Mark Edmund Johnston, MD FRCSC 13330 N 74th St, Omaha, NE 68122-1919 Ph: (402) 639-3250 |
News Archive
The Boston Globe: The town budget in Framingham, Mass. is strained, leading to layoffs and other cuts. "Everyone here seems to agree that a major factor is the rising cost of health care insurance for employees and retirees, which has jumped by $20 million in 10 years." The town picks up 87 percent of the premiums for most public employees and retirees, as negotiated through collective bargaining.
Among men with prostate cancer, African Americans experience longer treatment delays after being diagnosed than Caucasians. That is the finding of an analysis published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoPatch® SG pulmonary human cardiac patch processed with the Company's proprietary SynerGraft® technology. CryoLife's SynerGraft technology is designed to remove allogeneic donor cells and cellular remnants from tissue without compromising the integrity of the underlying collagen matrix.
Beginning this month, all patients undergoing cardiac catheterization at Vanderbilt University Medical Center will be tested for a genetic variation that can affect their response to Plavix, the most commonly prescribed clot-preventing drug for heart patients and one of the most commonly prescribed drugs worldwide.
The Mental Health Commission of Canada (MHCC) has partnered with the University of Calgary's Faculty of Medicine to evaluate a special course for second year medical students which aims to reduce the prejudice and discrimination associated with mental illness.
› Verified 1 days ago
Dr. Hythem Abouodah, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3902 Leavenworth St, Omaha, NE 68105 Phone: 402-559-2020 | |
Camilla Ruth Parson, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 16820 Frances St, Ste 100, Omaha, NE 68130 Phone: 402-933-6600 Fax: 402-933-7123 | |
Dr. Sebastian J Troia, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 515 N 98th St, Omaha, NE 68114 Phone: 402-399-9400 Fax: 402-399-8170 | |
Richard H Legge, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7810 Davenport St, Omaha, NE 68114 Phone: 402-397-1626 Fax: 402-397-1286 | |
Ahmad Halawa, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3902 Leavenworth St, Omaha, NE 68105 Phone: 402-559-3255 | |
Dr. Keegan Anthony Harkins, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3902 Leavenworth St, Omaha, NE 68105 Phone: 402-559-2020 | |
Anas L F Yasin, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 985540 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-1859 |